Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study-Reference-Cited by-同舟云学术

Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study

Published:2023-02-03 Issue:3 Volume:14 Page:569-579
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Uchida Taisuke^ORCID,Ueno Hiroaki^ORCID,Konagata Ayaka,Taniguchi Norifumi,Kogo Fumiko,Nagatomo Yuma,Shimizu Koichiro,Yamaguchi Hideki^ORCID,Shimoda Kazuya^ORCID

Funder

Saraya Co., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-023-01370-z.pdf

Reference30 articles.

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987;3(2):463–524. https://doi.org/10.1002/dmr.5610030206.

2. Creager MA, Lüscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108(12):1527–32. https://doi.org/10.1161/01.CIR.0000091257.27563.32.

3. Thijssen DHJ, Bruno RM, van Mil ACCM, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40(30):2534–47. https://doi.org/10.1093/eurheartj/ehz350.

4. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315(17):1046–51. https://doi.org/10.1056/NEJM198610233151702.

5. Henry RM, Ferreira I, Kostense PJ, et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not. Hoorn Study Atherosclerosis. 2004;174(1):49–56. https://doi.org/10.1016/j.atherosclerosis.2004.01.002.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study;Diabetes Therapy;2024-09-09

2. Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future;Biomedicines;2024-06-21

3. Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ;Cardiovascular Diabetology;2024-03-19

4. Improvement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg);Asploro Journal of Biomedical and Clinical Case Reports;2024-01-20

5. Comparative Analysis of Metformin and Imeglimin: Exploring Therapeutic Implications;Bangladesh Journal of Endocrinology and Metabolism;2024-01